Literature DB >> 18568532

Focal pancreatitis mimicking pancreatic mass: magnetic resonance imaging (MRI)/magnetic resonance cholangiopancreatography (MRCP) findings including diffusion-weighted MRI.

A J Momtahen1, N C Balci, S Alkaade, E I Akduman, F R Burton.   

Abstract

BACKGROUND: Focal pancreatitis (FP) is a confined inflammation that mimics a pancreatic mass. Its imaging diagnosis is important to avoid unnecessary procedures.
PURPOSE: To describe the spectrum of magnetic resonance imaging (MRI)/magnetic resonance cholangiopancreatography (MRCP) and diffusion-weighted MRI (DWI) findings of focal pancreatitis mimicking pancreatic masses.
MATERIAL AND METHODS: Findings of MRI/MRCP including DWI with a b value of 0 and 600 s/mm(2) in 14 patients with pancreatic masses on MRI were retrospectively reviewed and compared to normal pancreas in 14 patients as a control group.
RESULTS: FP revealed hypointense signal intensity (SI) (3/14), hypo- to isointense SI (7/14), or isointense SI (4/14) on T1-weighted images, and hypointense SI (1/14), isointense SI (5/14), iso- to hyperintense SI (7/14), or hyperintense SI (1/14) on T2-weighted images compared to remaining pancreas (RP). MRCP images revealed dilatation of the common bile duct (CBD) and main pancreatic duct (MPD) (5/14), dilatation of the MPD only (3/14), dilatation of the CBD only (3/14), and normal MPD and CBD (3/14). Both FP and RP revealed three types of time-signal intensity curves: 1) rapid rise to a peak, with a rapid decline (FP=2, RP=4), 2) slow rise to a peak, followed by a slow decline (FP=5, RP=4), and 3) slower rise to a peak, with a slow decline or plateau (FP=7, RP=6). Mean apparent diffusion coefficient (ADC) values for FP and RP were 2.09+/-0.18 and 2.03+/-0.2 x 10(-3) mm(2)/s, respectively. ADC values of FP and RP revealed no significant difference.
CONCLUSION: The spectrum of imaging findings of focal pancreatitis on MRI/MRCP including DWI was described. Findings of FP were not distinctive as compared to the remaining pancreas.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18568532     DOI: 10.1080/02841850802014602

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  7 in total

1.  Diffusion-weighted MRI: new paradigm for the diagnosis of interstitial oedematous pancreatitis.

Authors:  Massimo Tonolini; Salvatore Di Pietro
Journal:  Gland Surg       Date:  2019-04

Review 2.  Advanced MR Imaging of the Pancreas.

Authors:  Danielle V Hill; Temel Tirkes
Journal:  Magn Reson Imaging Clin N Am       Date:  2020-06-03       Impact factor: 2.266

3.  Effect of region of interest size on ADC measurements in pancreatic adenocarcinoma.

Authors:  Chao Ma; Xiaoyu Guo; Li Liu; Qian Zhan; Jing Li; Chengcheng Zhu; Li Wang; Jing Zhang; Xu Fang; Jianxun Qu; Shiyue Chen; Chengwei Shao; Jian-Ping Lu
Journal:  Cancer Imaging       Date:  2017-05-02       Impact factor: 3.909

Review 4.  Quantitative pancreatic MRI: a pathology-based review.

Authors:  Manil D Chouhan; Louisa Firmin; Samantha Read; Zahir Amin; Stuart A Taylor
Journal:  Br J Radiol       Date:  2019-06-14       Impact factor: 3.039

5.  Reproducibility of normalized apparent diffusion coefficient measurements on 3.0-T diffusion-weighted imaging of normal pancreas in a healthy population.

Authors:  Xun Ding; Haibo Xu; Jun Zhou; Jia Xu; Hao Mei; Qingyun Long; Yaxun Wang
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

6.  Differentiation of pancreatic carcinoma and mass-forming focal pancreatitis: qualitative and quantitative assessment by dynamic contrast-enhanced MRI combined with diffusion-weighted imaging.

Authors:  Ting-Ting Zhang; Li Wang; Huan-Huan Liu; Cai-Yuan Zhang; Xiao-Ming Li; Jian-Ping Lu; Deng-Bin Wang
Journal:  Oncotarget       Date:  2017-01-03

7.  Multifocal autoimmune pancreatitis: A retrospective study in a single tertiary center of 26 patients with a 20-year literature review.

Authors:  Xin-Ming Huang; Zhen-Shan Shi; Cheng-Le Ma
Journal:  World J Gastroenterol       Date:  2021-07-21       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.